BOULDER, Colo.--(BUSINESS WIRE)--Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ...
Covidien ($COV) won U.S. FDA 510(k) clearance for a combination laparoscopic surgical device. Known as the LigaSure laparoscopic sealer and divider, the device makes ...
Leading health care products company, Covidien plc. (COV) recently received 510(k) approval from the U.S. Food and Drug Administration (:FDA) for its LigaSure curved, small jaw, open sealer/divider ...
Medical device manufacturer Covidien has received approval from the FDA for its LigaSure surgical device, according to a report by the Boulder County Business Report. The LigaSure Curved, Small Jaw, ...
Covidien recently announced that the FDA has cleared its next generation LigaSure surgical tool. The company announced the 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic ...
BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ...
Medtronic has developed a portfolio of blood vessel sealing devices known as the LigaSure. By Reducing the cost of purchasing and manufacturing the device, Team 7 has designed the next step in ...
Laparoscopic Roux-en-Y gastric bypass (LRYGB) is one of the most preferred bariatric procedures in the world for surgical treatment of morbid obesity. The Harmonic scalpel (HS) and LigaSure (LS) are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback